Orion Capital Management’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Orion Capital Management’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-500	Closed	-$360	–	466
2022 Q4	$360	Hold	500	–	–	﹤0.01%	389
2022 Q3	$1K	Hold	500	–	–	﹤0.01%	396
2022 Q2	$1K	Hold	500	–	–	﹤0.01%	416
2022 Q1	$1K	Hold	500	–	–	﹤0.01%	403
2021 Q4	$1K	Hold	500	–	–	﹤0.01%	369
2021 Q3	$1K	Hold	500	–	–	﹤0.01%	369
2021 Q2	$2K	Hold	500	–	–	﹤0.01%	296
2021 Q1	$2K	Hold	500	–	–	﹤0.01%	289
2020 Q4	$2K	Buy	+500	New	+$2.11K	﹤0.01%	285

Other funds holding BLCM

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Orion Capital Management's BLCM Position: Q1 2023 in Review

Orion Capital Management sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q1 2023, closing a stake of 500 shares — an estimated $360 sold.

Orion Capital Management first reported a position in BLCM in Q4 2020 and held it in 9 quarters. The position peaked at $2K in Q2 2021. 25 funds tracked by Wall St. Rank hold BLCM as of Q1 2023.

Orion Capital Management reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Orion Capital Management sold 500 Bellicum Pharmaceuticals, Inc. shares in Q1 2023, an estimated $360.
Orion Capital Management first reported a position in Bellicum Pharmaceuticals, Inc. in Q4 2020 and held it in 9 quarters.
Orion Capital Management's Bellicum Pharmaceuticals, Inc. position peaked at $2K in Q2 2021.
25 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q1 2023.

Based on Orion Capital Management's 13F filing for Q1 2023, filed 10 May 2023.